Invitation to Roche ’s Full Year Results 2023 Presentation

  Roche will publish its Full Year Results of 2023 prior to the opening of the Swiss Stock Exchange onThursday,1 February 2024.07:00 CET / 06:00 GMT / 01:00 AM EST / 10:00 PM PST (evening before)Release will be e-mailed and posted on the Roche IR website>click herePresentation slides will be posted on the Roche IR website>click here14:00 – 16:00 CET / 13:00 – 15:00 GMT08:00 – 10:00 AM EST / 05:00 - 07:00 AM PSTThe webinar  will start with presentations by senior management, followed by a Q&A session.Presenters:Thomas Schinecker, CEO Roche GroupTeresa Graham, CEO Roche PharmaceuticalsMatt Sause, CEO Roche Diagnostics  Alan Hippe, Chief Financial and IT Officer Roche We would like to invite all interested parties to participate in the webinar and to pre-register for the eventhere.*Should you be unable to register for the webinar due to your company IT policy, please send an email [e-mail].A replay of the webinar will be available via>ir.roche.com*privacy noticeBest regards,  Bruno EschliHead of Investor Relations    Roche Investor Relations Dr. Bruno EschliPhone: [phone]e-mail:[e-mail] Dr. Sabine Borngr äberPhone: [phone]e-mail:[e-mail] Dr. Birgit MasjostPhone: [phone]e-mail:[e-mail]    Investor Relations North America Loren KalmPhone: [phone]e-mail:[e-mail]  

Source: Roche Investor Update - December 19, 2023 Category: Pharmaceuticals Source Type: news